|
Although
not usually life-threatening, diarrheal and more severe
clinical variants of dysentery can compromise a military
mission because of their potential for rapid transmission.
AFRIMS has been a world leader in developing rapid and accurate
diagnostic techniques for the etiological agents of diarrheal
disease. Remarkable success has been achieved in recognizing
diarrheagenic E. coli strains and in the identification
of non-culturable enteric pathogens using DNA probes and
PCR technology. Primers have been identified for the major
targets and work focuses on inhibitor removal for PCR sample
preparation. New causes of diarrhea have been identified
by AFRIMS scientists working throughout Asia. Recently,
a new agent of chronic diarrhea, Cyclospora, was
identified at the field site in Nepal. Additionally, there
are studies underway to track the widespread emergence of
multiple antibiotic resistance in a number of different
etiologic agents. A new attenuated Shigella vaccine is being
tested for safety and community spread at the International
Centre for Diarrhoeal Diseases Research, Bangladesh (ICDDR,B).
|
|

Collecting
clinical data and stool specimens from children with diarrhea,
Children’s Hospital, Bangkok, Thailand.
|